TY - JOUR
T1 - A New Guideline on Treatment of Hypertension in Those with Coronary Artery Disease. Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension About Treatment of Hypertension in Patients with Coronary Artery Disease
AU - Jennings, Garry L.R.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Hypertension is a major risk factor for coronary artery disease (CAD) and the two frequently coexist. The peak cardiology and hypertension societies of the United States recently published new guidelines on the treatment of hypertension in people with CAD. The guidelines update those previously issued eight years previously in the light of new trial data. However, for the most part they will validate what cardiologists are already doing in these patients. The major change is resetting of the blood pressure general treatment target for most people with hypertension and CAD from 130/80 mm Hg to 140/90 mm Hg. It is arguable that the evidence supporting the new target is any stronger than that supporting the old. While this will remain controversial in the absence of good data on the relative benefits of different treatment targets in hypertension it is in line with trends from a number of other general hypertension guidelines.
AB - Hypertension is a major risk factor for coronary artery disease (CAD) and the two frequently coexist. The peak cardiology and hypertension societies of the United States recently published new guidelines on the treatment of hypertension in people with CAD. The guidelines update those previously issued eight years previously in the light of new trial data. However, for the most part they will validate what cardiologists are already doing in these patients. The major change is resetting of the blood pressure general treatment target for most people with hypertension and CAD from 130/80 mm Hg to 140/90 mm Hg. It is arguable that the evidence supporting the new target is any stronger than that supporting the old. While this will remain controversial in the absence of good data on the relative benefits of different treatment targets in hypertension it is in line with trends from a number of other general hypertension guidelines.
KW - Absolute risk assessment
KW - CAD
KW - Coronary Artery Disease
KW - Hypertension
UR - https://www.scopus.com/pages/publications/84944513373
U2 - 10.1016/j.hlc.2015.05.022
DO - 10.1016/j.hlc.2015.05.022
M3 - Editorial
C2 - 26205991
AN - SCOPUS:84944513373
SN - 1443-9506
VL - 24
SP - 1037
EP - 1040
JO - Heart Lung and Circulation
JF - Heart Lung and Circulation
IS - 11
ER -